INGRASCIOTTA, Ylenia
 Distribuzione geografica
Continente #
EU - Europa 1.049
NA - Nord America 956
AS - Asia 634
SA - Sud America 108
AF - Africa 42
Totale 2.789
Nazione #
US - Stati Uniti d'America 927
RU - Federazione Russa 702
SG - Singapore 277
CN - Cina 142
HK - Hong Kong 87
BR - Brasile 83
IT - Italia 74
GB - Regno Unito 55
DE - Germania 51
VN - Vietnam 44
FI - Finlandia 37
FR - Francia 33
KR - Corea 26
IE - Irlanda 25
CA - Canada 17
NL - Olanda 17
BJ - Benin 15
AR - Argentina 14
PL - Polonia 14
TG - Togo 12
JP - Giappone 11
MX - Messico 11
SE - Svezia 11
ZA - Sudafrica 10
AT - Austria 9
TR - Turchia 9
IN - India 8
BD - Bangladesh 5
CO - Colombia 5
ES - Italia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
ID - Indonesia 3
IQ - Iraq 3
PT - Portogallo 3
SA - Arabia Saudita 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
GR - Grecia 2
HR - Croazia 2
LT - Lituania 2
LV - Lettonia 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SD - Sudan 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.789
Città #
Dallas 466
Moscow 270
Singapore 133
Ashburn 112
Hong Kong 87
Verona 36
Beijing 33
Los Angeles 32
Dublin 25
New York 24
London 22
Munich 21
Helsinki 20
Ho Chi Minh City 17
Buffalo 16
Cotonou 15
Santa Clara 15
Chandler 14
The Dalles 14
Turku 13
Lomé 12
Redondo Beach 11
Seattle 11
Tokyo 11
Warsaw 11
Amsterdam 10
Brooklyn 10
Montreal 10
Orem 9
Seoul 8
Stockholm 8
Sindelfingen 7
São Paulo 7
Boardman 6
Columbus 6
Johannesburg 6
Lawrence 6
Manchester 6
Mexico City 6
Princeton 6
Hanoi 5
Nuremberg 5
Poplar 5
Tianjin 5
Wilmington 5
Ankara 4
Boston 4
Changsha 4
Chicago 4
Denver 4
Frankfurt am Main 4
Houston 4
Jacksonville 4
Mumbai 4
Tashkent 4
Toronto 4
Vienna 4
Biên Hòa 3
Campinas 3
City of London 3
Englewood 3
Falkenstein 3
Lappeenranta 3
Mirano 3
Rio de Janeiro 3
Rome 3
San Francisco 3
Shanghai 3
Shenzhen 3
Wroclaw 3
Athens 2
Atlanta 2
Bogotá 2
Boydton 2
Brasília 2
Carney 2
Catania 2
Chennai 2
Chions 2
Dong Ket 2
Dongguan 2
Fortaleza 2
Genoa 2
Guangzhou 2
Haiphong 2
Hefei 2
Jiaxing 2
Maastricht 2
Medellín 2
Mistretta 2
Naaldwijk 2
Nanjing 2
Olomouc 2
Phoenix 2
Pietrasanta 2
Piracicaba 2
Porto 2
Porto Alegre 2
Querétaro 2
Riga 2
Totale 1.724
Nome #
Real-World Polypharmacy and Drug-Drug Interactions in a Large Cohort of Direct Oral Anticoagulant Users With Atrial Fibrillation 154
Safety Assessment of Biologics for Immune-Mediated Inflammatory Diseases Using Italian VALORE Healthcare Database Network and National Spontaneous Reporting System 150
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 119
Comment on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project". [Response to Letter] 113
Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis 109
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 108
Biosimilars in Italy: what do real-world data reveal? 98
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network 97
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis 91
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project 91
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 90
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries 90
Hidradenitis suppurativa and psoriasis: the odd couple 89
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 88
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review 86
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project 82
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments 81
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies 79
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials 79
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 78
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network 75
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients' Unmet Needs and Exploring Future Applications 72
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project 72
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 67
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project 65
Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study 62
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 62
Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world 60
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 56
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo 54
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 54
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context 49
Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network 46
Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian valore distributed database network 43
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed Database 34
null 22
Totale 2.865
Categoria #
all - tutte 9.096
article - articoli 8.896
book - libri 0
conference - conferenze 200
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 6 0 3 4
2021/202235 3 7 1 0 0 0 0 0 1 4 6 13
2022/202368 9 4 10 15 0 19 5 0 4 2 0 0
2023/2024213 9 12 17 25 12 13 25 13 1 21 34 31
2024/2025493 40 11 37 66 13 45 26 26 50 52 50 77
2025/20262.043 110 382 304 433 724 90 0 0 0 0 0 0
Totale 2.865